MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
28.51
-0.92
-3.13%
After Hours: 28.80 +0.29 +1.02% 16:57 09/28 EDT
OPEN
29.00
PREV CLOSE
29.43
HIGH
29.52
LOW
28.07
VOLUME
2.64M
TURNOVER
--
52 WEEK HIGH
29.96
52 WEEK LOW
12.00
MARKET CAP
4.55B
P/E (TTM)
-69.8946
1D
5D
1M
3M
1Y
5Y
1D
Biotech Stocks At 52-Week Highs - CDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY
NASDAQ · 3d ago
Is Bio-Techne Stock Outperforming the Nasdaq?
Barchart · 4d ago
How NCCN Guideline Changes At Adaptive Biotechnologies (ADPT) Have Changed Its Investment Story
Simply Wall St · 5d ago
Craig-Hallum sees potential for confusion after CMS fee schedule
TipRanks · 6d ago
Craig-Hallum warns CMS Lab Fee proposal may spur confusion across genomics names
TipRanks · 6d ago
Adaptive Biotechnologies Is Maintained at Buy by BTIG
Dow Jones · 6d ago
Adaptive Biotechnologies Price Target Raised to $34.00/Share From $25.00 by BTIG
Dow Jones · 6d ago
BTIG Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $34
Benzinga · 6d ago
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its technologies to read the genetic code of a patient's immune system. It operates through two segments, which include Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic testing service, offered to clinicians. Its Immune Medicine business focuses on immune-repertoire sequencing, target antigen discovery, data licensing and TCR-antigen prediction models in the identification, validation, development and adoption of products and services.

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.